Clinigen
Clinigen Group plc, headquartered in the United Kingdom, is a leading global pharmaceutical and services company specialising in the provision of access to medicines. Founded in 2010, Clinigen has rapidly established itself in the healthcare industry, focusing on unlicensed and niche products, clinical trial services, and the management of complex supply chains.
With a strong presence in Europe, North America, and Asia, Clinigen offers unique solutions that bridge the gap between pharmaceutical companies and patients. Their core services include the provision of clinical trial supplies and the management of access programmes, ensuring that patients receive critical treatments when they need them most. Clinigen's commitment to patient access and innovative solutions has positioned it as a trusted partner in the global healthcare landscape, achieving significant milestones in expanding its product offerings and market reach.
+30 vs industry average
Clinigen’s score of 68 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Clinigen?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Clinigen's reported carbon emissions
In 2024, Clinigen reported total greenhouse gas emissions of approximately 39,000,000 kg CO2e, comprising 567,000 kg CO2e from Scope 1, 2,133,000 kg CO2e from Scope 2 (market-based), and 36,000,000 kg CO2e from Scope 3 emissions. In 2023, the company recorded total emissions of about 35,000,000 kg CO2e, with Scope 1 emissions at 662,000 kg CO2e, Scope 2 at 2,910,000 kg CO2e, and Scope 3 at 32,035,000 kg CO2e. Clinigen has set ambitious reduction targets, aiming for a 42% reduction in absolute Scope 1 and 2 GHG emissions by 2030, using 2023 as the base year. Additionally, the company commits to a 90% reduction in absolute Scope 1, 2, and 3 emissions by 2040. These targets align with the Science Based Targets initiative (SBTi) and are designed to support the global effort to limit warming to 1.5°C. Clinigen's long-term commitment includes achieving net-zero emissions across its entire value chain by 2040. This comprehensive approach reflects the company's dedication to sustainability and climate responsibility within the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Clinigen’s Climate Goals (2030 & 2050)
1 goal2040
90% reduction in all scopes
reduction in absolute scope 1, 2 and 3 GHG emissions by 2040
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 1 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Clinigen’s sustainability data and climate commitments
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project